Anticoagulants for subclinical atrial fibrillation
Сазонова Y. С., Андреев Д. А., Сыркин А. Л., Serova M. V., Самойленко И. В.
Кардиология и сердечно-сосудистая хирургия
Т. 12, Вып. 5, С. 441-449
Опубликовано: 2019
Тип ресурса: Статья
DOI:10.17116/kardio201912051441
Аннотация:
Objective — to study the indications for oral anticoagulation in patients with subclinical atrial fibrillation (SCAF) depending on risk factors and features of arrhythmia. Material and methods. A prospective single-center study included 304 patients with no previous atrial fibrillation (AF) who underwent pacemaker implantation or replacement. The patients were monitored every 3 months for 1 year. Device data were evaluated regarding atrial arrhythmias during control survey. Atrial high rate episodes lasting over 6 min per day with a frequency of atrial events over 175—180 beats per minute were considered significant. The decision on antithrombotic therapy was made based on intracardiac electrograms (EGM) and analysis of risk of thromboembolic events. Results. Only 255 out of 304 patients were available for the first follow-up, 224 patients were followed-up throughout a year. SCAF was diagnosed in 57 (22.3[%]) patients. According to analysis of intracardiac EGM, true atrial fibrillation w
Ключевые слова:
Anticoagulants; Atrial high rate episodes; Cardiac implantable electronic devices; Secondary atrial fibrillation; Subclinical atrial fibrillation
Язык текста: Русский
ISSN: 2309-4737
Сазонова Y. С.
Андреев Д. А. Денис Анатольевич 1968-
Сыркин А. Л. Абрам Львович 1930-
Serova M. V.
Самойленко И. В. Игорь Васильевич 1967-
Sazonova Y. S.
Andreev D. A. Denis Anatolyevich 1968-
Sy'rkin A. L. Abram L`vovich 1930-
Серова М. В.
Samojlenko I. V. Igor` Vasilyevich 1967-
Anticoagulants for subclinical atrial fibrillation
Текст визуальный непосредственный
Кардиология и сердечно-сосудистая хирургия
Издательство Медиа Сфера
Т. 12, Вып. 5 С. 441-449
2019
Статья
Anticoagulants Atrial high rate episodes Cardiac implantable electronic devices Secondary atrial fibrillation Subclinical atrial fibrillation
Objective — to study the indications for oral anticoagulation in patients with subclinical atrial fibrillation (SCAF) depending on risk factors and features of arrhythmia. Material and methods. A prospective single-center study included 304 patients with no previous atrial fibrillation (AF) who underwent pacemaker implantation or replacement. The patients were monitored every 3 months for 1 year. Device data were evaluated regarding atrial arrhythmias during control survey. Atrial high rate episodes lasting over 6 min per day with a frequency of atrial events over 175—180 beats per minute were considered significant. The decision on antithrombotic therapy was made based on intracardiac electrograms (EGM) and analysis of risk of thromboembolic events. Results. Only 255 out of 304 patients were available for the first follow-up, 224 patients were followed-up throughout a year. SCAF was diagnosed in 57 (22.3[%]) patients. According to analysis of intracardiac EGM, true atrial fibrillation w